If you've had genetic testing done, you may have heard about MTHFR mutations and seen supplement recommendations tied to your results. The MTHFR gene encodes an enzyme that converts dietary folate into its active form, methylfolate (5-MTHF). Variants in this gene are common—present in 30–40% of the population—yet most people carrying them experience no symptoms or health problems. Understanding whether MTHFR supplementation is right for you requires separating hype from evidence.

What Is MTHFR and Why It Matters

The methylenetetrahydrofolate reductase (MTHFR) enzyme catalyzes a critical step in the one-carbon cycle, a metabolic pathway that produces methylation cofactors needed for DNA synthesis, neurotransmitter production, and detoxification. When you consume folate from food or supplements, your body must convert it through several steps into its active form, 5-methyltetrahydrofolate (5-MTHF), which enters cells and participates in methylation reactions.

MTHFR gene variants—most commonly C677T and A1298C—reduce enzyme activity by 35% to 65% depending on whether you carry one or two copies of the variant allele. However, having a mutation does not automatically mean your folate metabolism is impaired. Enzyme activity typically remains sufficient for normal function, especially if dietary folate intake is adequate. The clinical significance of MTHFR variants remains controversial among researchers and clinicians, with many experts noting that genetic status alone is a poor predictor of folate-dependent health problems.

The Role of Folate Metabolism in Health

Folate and its active form, methylfolate, are essential for several physiological functions. The one-carbon cycle—in which methylfolate participates—generates methyl groups used to:

Actual folate deficiency—confirmed by low serum or red blood cell folate levels—is associated with anemia, neural tube defects in pregnancy, and potentially elevated homocysteine. People with MTHFR mutations who also have inadequate folate intake, certain genetic polymorphisms in other folate-metabolism genes, or conditions affecting absorption (such as celiac disease or inflammatory bowel disease) may be at higher risk for functional folate insufficiency. However, most individuals with MTHFR variants alone do not become deficient.

Understanding Methylfolate and 5-MTHF Supplements

Methylfolate, or 5-MTHF, is the active, already-reduced form of folate. Unlike synthetic folic acid (which must be converted through a series of enzymatic steps to 5-MTHF), methylfolate bypasses the initial reduction steps and the MTHFR enzyme itself. This is the rationale behind recommending methylfolate to people with MTHFR variants: if the MTHFR enzyme is less efficient, providing the final metabolite directly may theoretically provide folate support without relying on that enzyme.

Methylfolate supplements are typically supplied as calcium L-methylfolate or other salt forms. Doses commonly range from 500 mcg to 5,000 mcg (5 mg) per day. The vitamin is well-absorbed orally and crosses the blood-brain barrier more efficiently than some other folate forms, which is one reason it has generated interest for neurological and psychiatric support.

However, evidence that methylfolate is superior to regular folate for people with MTHFR mutations is limited. Most studies comparing folate forms were conducted in cell cultures or animals; robust randomized controlled trials in humans are scarce. Some small observational studies and clinical reports suggest methylfolate may be helpful for mood, energy, or cognitive symptoms in certain individuals, but these lack rigorous controls and cannot establish cause and effect.

Evidence for MTHFR Supplementation in Common Health Concerns

Several health conditions have been speculatively linked to MTHFR mutations, often fueled by integrative practitioners and online communities. Here is what the evidence actually shows:

Mood and Mental Health: Folate plays a role in neurotransmitter synthesis, and folate deficiency is associated with depression. Some small case series report that methylfolate supplementation may improve depressive symptoms in certain individuals, especially those with low folate levels. However, no large randomized trials have compared methylfolate to placebo in MTHFR-variant carriers with depression. Claims that MTHFR mutations